This international, multicenter cohort study aims to investigate outcomes after treatment
      with extracorporeal cardiopulmonary resuscitation (eCPR) during cardiac arrest.

ECMELLA vs. ECMO on 30-day Mortality

Cardiac Arrest

Cardiopulmonary Arrest

Extracorporeal Membrane Oxygenation Complication

Cardiogenic Shock

Acute Myocardial Infarction

Left ventricular unloading with Impella® micro-axial pump has been shown to improve survival
      in patients with cardiogenic shock treated with veno-arterial extracorporeal membrane
      oxygenation (VA-ECMO). This study aims to investigate whether treatment with VA-ECMO and
      Impella ® (so called "ECMELLA") during extracorporeal cardiopulmonary resuscitation is
      associated with improved outcomes.

VA-ECMO

ECMELLA

Treatment With Leftventricular Impella® Micro-axial Pump and Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) During Extracorporeal Cardiopulmonary Resuscitation (eCPR) on Mortality - An International Multicenter Cohort Study

Mortality within 30 days after cardiac arrest event.

Professor

Number of days between hospital admission and hospital discharge.

Number of ICU days between ICU admission and ICU discharge.

Patients who were treated with veno-arterial extracorporeal membrane oxygenation (VA-ECMO) during cardiac arrest.

Patients who were treated with veno-arterial extracorporeal membrane oxygenation (VA-ECMO) and Impella® micro-axial pump.

ECMELLA vs. ECMO on 30-day Mortality

About this trial

Study ID

Status

Type

Placebo

Accepting

Not accepting

Trial Timing

What is this trial about?

What are the participation requirements?

Locations

Location

Status